Health Apr 06 Drug companies paid $116 million to patient advocacy groups in 2015 alone, new data suggests The database, called Pre$cription for Power shows that donations to patient advocacy groups tallied for 2015 — the most recent full year in which documents required by the Internal Revenue Service were available — dwarfed the total amount the companies…
Health Sep 06 Outcry over EpiPen highlights FDA’s long backlog of generics As of July 1, the FDA had 4,036 generic drug applications awaiting approval. The FDA has approved more generics the past few years, but a flood of new applications has steadily added to the demand.